Jessica Shore
Vice President -Research and Programs, Pulmonary Fibrosis Foundation
Uncovering the Clinical Research Propelling ILD Drug Development Forwards in 2022 & Beyond
9:00 am
Strategically Leveraging ILD Clinical Trials to Further Our Understanding of The Progressive Pulmonary Fibrosis Phenotype & Identify Novel Outcomes in Clinical Trials
Craig Conoscenti
Medical Expert ILD Respiratory Clinical Development & Medical Affairs, Boehringer Ingelheim